Lumos Pharma Inc. (LUMO)
NASDAQ: LUMO
· Real-Time Price · USD
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 10:00 PM
Lumos Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -34.92M | -35.75M | -37.13M | -34.03M | -32.82M | -31.77M | -30.69M | -31.06M | -28.46M | -28.69M | -29.52M | -30.43M | -27.2M | -17.95M | -14.63M |
Depreciation & Amortization | 21K | 30K | 37K | 44K | 61K | 57K | 46K | 49K | 23K | 27K | 45K | 203K | 403K | 550K | 716K |
Stock-Based Compensation | 1.87M | 2.05M | 2.32M | 2.32M | 2.38M | 2.42M | 2.34M | 2.32M | 2.23M | 2.12M | 2.4M | 2.88M | 2.7M | 2.52M | 1.95M |
Other Working Capital | -1.13M | -1.36M | -1.45M | 679K | 2.04M | 2.19M | 2.32M | -382K | 430K | -92K | 1.04M | 469K | 2.55M | 9.47M | 1.27M |
Other Non-Cash Items | 2.69M | 2.77M | 2.77M | -551K | -388K | 382K | 1.5M | 2.11M | -21.93M | -22.61M | -23.58M | -21.32M | -2.19M | -8.46M | -14.02M |
Deferred Income Tax | 159K | 159K | 159K | 159K | n/a | n/a | -984K | -984K | 23.08M | 23.08M | 24.07M | 24.07M | -4.65M | -7.08M | -8.51M |
Change in Working Capital | 1.55M | -696K | 241K | 965K | 1.24M | 2.37M | 676K | 2.1M | -419K | -1.6M | -204K | -2.31M | -2.06M | 4.86M | -3.35M |
Operating Cash Flow | -31.67M | -34.49M | -34.79M | -31.09M | -29.53M | -27.23M | -27.79M | -26.62M | -26.63M | -28.14M | -27.27M | -29.65M | -30.8M | -23.37M | -30.1M |
Capital Expenditures | -13.21M | -6.83M | -10.74M | -13.21M | -21K | -6.4M | -2.48M | -21K | -13K | -20K | -30K | -30K | -29K | -26K | -30K |
Cash Acquisitions | 7.03M | 1.08M | n/a | n/a | -7.03M | -1.08M | n/a | n/a | n/a | n/a | n/a | n/a | -84.18M | -84.18M | -84.18M |
Purchase of Investments | -998K | -7.38M | -11.29M | -13.76M | -24.1M | -17.72M | -13.8M | -11.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 8.17M | 14.12M | 19.12M | 18.12M | 10.95M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 6.17M | 13.12M | 17.04M | 18.5M | 993K | -4.96M | -8.87M | -11.34M | -20K | -20K | -30K | 25.97M | 110.17M | 142.67M | 142.66M |
Investing Cash Flow | 7.17M | 13.12M | 14.21M | 10.74M | -6.79M | -12.74M | -13.82M | -11.36M | -13K | -20K | -30K | 25.97M | 25.97M | 58.47M | 58.47M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11K | -11K |
Common Stock Repurchased | n/a | -442K | -1.01M | -1.31M | -1.79M | -1.56M | -1.01M | -712K | -234K | -37K | -75K | -114K | -114K | -114K | -44K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3K | -8K | 8K | 9K | -5K | -125K | -132K | -146K | -149K | -20K | -44K | -192K | -96K | -96K | -86K |
Financial Cash Flow | 2.46M | 302K | -272K | -576K | -1.79M | -1.68M | -1.11M | -821K | -346K | -20K | -44K | -192K | -96K | -107K | -91K |
Net Cash Flow | -22.04M | -21.06M | -20.86M | -20.93M | -38.11M | -41.65M | -42.72M | -38.8M | -26.98M | -28.18M | -27.34M | -3.87M | -4.92M | 35M | 28.28M |
Free Cash Flow | -44.88M | -41.31M | -45.53M | -44.3M | -29.55M | -33.63M | -30.27M | -26.64M | -26.64M | -28.16M | -27.3M | -29.68M | -30.83M | -23.39M | -30.13M |